Midwifery Pharmacology — The Limited Formulary - Misconception Buster
Pharmacology is one of the highest-stakes topics in the PRC Midwife Licensure Examination. Every year, examinees lose points — sometimes failing — because they carry wrong beliefs about what drugs a midwife can give, what doses are correct, and what situations call for referral rather than treatment. This guide targets the most dangerous wrong beliefs that Filipino midwifery reviewees hold about the limited formulary. Unlike a plain reviewer, this material shows you exactly WHERE your thinking goes wrong, WHY it sounds convincing, and HOW to rewire your understanding before exam day. Study each misconception carefully: the trap questions here are designed exactly like items that appear on the MLE. If you can answer the trap questions correctly AND explain why, you are ready.
Common misconceptions
A midwife can give oxytocin to speed up a slow labor (to induce or augment contractions) because oxytocin is within the midwife's formulary.
Exam impact
Board exam items frequently describe a prolonged labor scenario and ask what the midwife should do. Examinees who hold this misconception choose 'administer oxytocin to augment contractions' instead of the correct answer: 'refer to a physician or higher-level facility immediately.' This single wrong belief can cost several marks across related questions.
The reality
Oxytocin is in the midwife's formulary for ONE purpose only: the THIRD STAGE of labor (AMTSL — Active Management of the Third Stage) and PPH treatment AFTER the baby is born. Using oxytocin BEFORE delivery to induce or augment labor is STRICTLY a physician's act under RA 7392. Giving oxytocin during labor (before birth) can cause uterine hyperstimulation, uterine rupture, placental abruption, and fetal death. The midwife's drug is the same, but the timing and purpose make all the difference — and the law draws a firm line here.
Trap question
Question
A G2P1 woman at 39 weeks AOG is in active labor at the BHS. The midwife notes that uterine contractions are irregular and mild despite 8 hours of active labor. There is no second twin. What is the MOST appropriate action of the midwife?
Prolonged or dysfunctional labor is an OBSTETRIC COMPLICATION. Oxytocin for induction or augmentation of labor is a PHYSICIAN'S ACT. The midwife's oxytocin is given only AFTER birth of the baby as part of AMTSL (or for PPH). The correct action here is detection of the complication and REFERRAL — not treatment with oxytocin.
Wrong answer
Administer oxytocin 10 IU IM to augment uterine contractions.
Correct answer
Refer the patient immediately to a physician or higher-level facility (RHU/BEmONC hospital).
Correct vs incorrect approach
Correct approach
Midwife sees 'prolonged labor / abnormal labor progress' → recognizes this as a COMPLICATION → REFERS immediately to physician or BEmONC/CEmONC facility. Oxytocin administration is reserved strictly for AFTER the baby is delivered (third stage / PPH).
Incorrect approach
Student sees 'prolonged labor / weak contractions' → thinks 'oxytocin strengthens uterine contractions → midwife has oxytocin → give oxytocin to augment labor.' This kills patients and violates RA 7392.
Why students believe it
Reviewees memorize 'oxytocin is in the midwife's formulary' and logically conclude that if they have the drug, they can use it any time uterine contractions are needed. It seems reasonable: if oxytocin strengthens contractions after birth, why not before? This is the single most dangerous reasoning error in the formulary topic.
Ergometrine (methylergometrine) is interchangeable with oxytocin as the first-line drug for AMTSL — both are uterotonics, so either can be used first.
Exam impact
Exam items frequently ask 'which drug is the drug of choice for AMTSL' or 'which uterotonic is safest when BP is unknown.' Choosing ergometrine over oxytocin as first-line loses marks and reflects unsafe practice.
The reality
Oxytocin 10 IU IM is ALWAYS the FIRST-LINE drug for AMTSL. Ergometrine is SECOND-LINE and has a critical contraindication: it raises blood pressure through vasoconstriction. It is ABSOLUTELY CONTRAINDICATED in hypertension, pre-eclampsia, eclampsia, and heart disease. Because a midwife in the community often cannot fully rule out hypertension at the moment of delivery, oxytocin is the universally safer default. Ergometrine is a backup when oxytocin is unavailable or insufficient — never the automatic first choice.
Trap question
Question
Immediately after delivery of the baby at a BHS, the midwife is about to administer the AMTSL uterotonic. The patient's last recorded BP was not available. Which drug is MOST appropriate to give first?
Oxytocin is the drug of choice for AMTSL precisely because it does not cause vasoconstriction or raise BP. Ergometrine is contraindicated if hypertension cannot be excluded. Since BP is unknown here, oxytocin is the only safe first choice. This is a classic trap: both are uterotonics, but SAFETY profile determines first-line status.
Wrong answer
Ergometrine 0.2 mg IM because it produces a stronger and longer uterine contraction.
Correct answer
Oxytocin 10 IU IM because it is effective and does NOT elevate blood pressure, making it safer when BP status is unknown.
Correct vs incorrect approach
Correct approach
After delivery of the baby (no second twin confirmed), give OXYTOCIN 10 IU IM within 1 minute — it is effective AND does NOT raise BP. Ergometrine 0.2 mg IM is used ONLY if oxytocin is unavailable or PPH is not controlled, AND after confirming there is NO hypertension.
Incorrect approach
Student sees 'uterotonic needed after birth' → picks ergometrine because it is 'stronger' or because BP was not measured → patient with undetected hypertension receives ergometrine → dangerous BP spike.
Why students believe it
Both oxytocin and ergometrine are taught as uterotonics used to prevent PPH. Students often confuse 'available uterotonic' with 'first-line uterotonic for AMTSL.' Old textbooks listed ergometrine prominently, so some reviewees remember it as equally valid or even more potent.
The MgSO4 loading dose for eclampsia is only given IV — the IM component is optional or unnecessary.
Exam impact
MLE questions about eclampsia loading frequently test the complete regimen. Selecting 'only 4 g IV' or confusing doses loses marks on what is a heavily tested item.
The reality
The standard loading regimen as taught for the MLE is BOTH routes simultaneously: 4 g MgSO4 (20% solution) slow IV over 5–20 minutes, PLUS 5 g MgSO4 (50% solution) IM into EACH buttock (10 g total IM), with each IM dose mixed with 1 mL of 2% lignocaine to reduce pain. Together that is 4 g IV + 10 g IM = 14 g total loading dose. The IM component extends therapeutic levels while the patient is being transported. Omitting the IM portion leaves the seizing patient underprotected during referral.
Trap question
Question
A primigravida at 36 weeks develops generalized tonic-clonic seizures at the BHS. The midwife diagnoses eclampsia and prepares MgSO4 as a pre-referral loading dose. Which of the following correctly describes the COMPLETE loading regimen?
The MgSO4 loading dose involves BOTH IV and IM routes given simultaneously. The IV component provides rapid therapeutic levels; the IM component sustains levels during referral. Omitting the IM portion leaves the patient vulnerable to recurrent seizures. Memorize: 4 g IV + 10 g IM (5 g each buttock) = complete loading dose.
Wrong answer
4 g MgSO4 IV over 5–20 minutes only.
Correct answer
4 g MgSO4 (20% solution) slow IV over 5–20 minutes, PLUS 5 g MgSO4 (50% solution) with 1 mL of 2% lignocaine deep IM into each buttock (10 g total IM).
Correct vs incorrect approach
Correct approach
Eclampsia detected → give loading dose: 4 g MgSO4 (20%) slow IV over 5–20 min + 5 g MgSO4 (50%) with 1 mL lignocaine IM into each buttock (10 g total IM) → check safety signs → arrange IMMEDIATE referral → maintenance (5 g IM every 4 h alternate buttocks) is a PHYSICIAN/FACILITY responsibility.
Incorrect approach
Student sees eclampsia → recalls 'MgSO4 4 g IV' → administers only IV portion → misses the IM loading doses → patient may seize again during transfer because serum levels drop.
Why students believe it
Students often memorize the IV loading dose (4 g IV) as the main event and treat the IM doses as 'just extra.' Some older reviews present only the IV portion, and students assume the IM part is an alternative rather than a combined simultaneous loading regimen. The IV dose feels like the 'real' medicine while the IM dose seems like a backup.
When monitoring a patient on MgSO4, checking reflexes alone is sufficient — the other safety parameters (respiratory rate and urine output) are secondary.
Exam impact
MLE items about MgSO4 monitoring frequently list 3–4 options testing whether the student knows the FULL triad or only reflexes. Selecting 'patellar reflex only' loses marks and demonstrates incomplete safety knowledge.
The reality
ALL THREE safety signs must be present before each MgSO4 dose: (1) Respiratory rate ≥ 12–16 breaths per minute, (2) Urine output ≥ 30 mL/hour (or ≥ 100 mL in the preceding 4 hours), and (3) Patellar (knee-jerk) reflexes present. Respiratory depression is the MOST LETHAL sign of MgSO4 toxicity — a patient can die from apnea before losing reflexes. Urine output matters because MgSO4 is renally excreted; oliguria causes rapid accumulation to toxic levels. The ANTIDOTE is calcium gluconate 1 g (10 mL of 10% solution) slow IV — the midwife must have this ready at the bedside.
Trap question
Question
A patient with eclampsia received the MgSO4 loading dose at the BHS. While awaiting transfer, her knee-jerk reflexes are present but her respiratory rate is 9 breaths per minute. What should the midwife do IMMEDIATELY?
A respiratory rate of 9/min is BELOW the safe threshold of 12–16/min and indicates MgSO4 toxicity. The presence of patellar reflexes does NOT override an abnormal RR. Respiratory depression is the most life-threatening sign of MgSO4 overdose. All three safety signs must be met — not just one. The antidote is calcium gluconate, NOT more MgSO4.
Wrong answer
Continue monitoring and proceed with transport since the patellar reflex is present.
Correct answer
STOP MgSO4, administer calcium gluconate 1 g (10 mL of 10% solution) slow IV as the antidote, and arrange urgent referral.
Correct vs incorrect approach
Correct approach
Before every MgSO4 dose and during monitoring: CHECK ALL THREE — (1) RR ≥ 12–16/min, (2) urine ≥ 30 mL/hr, (3) patellar reflex present. If ANY one is absent or below threshold → STOP MgSO4 → give calcium gluconate 1 g slow IV → refer immediately.
Incorrect approach
Student checks only knee-jerk reflex → misses that RR has dropped to 10/min → MgSO4 toxicity goes unrecognized → respiratory arrest → patient dies.
Why students believe it
Patellar reflex is the most memorable and quickest bedside check, so many reviewees focus only on it. Exam review materials sometimes emphasize 'check knee jerk' without equally emphasizing the full triad, leading students to deprioritize RR and urine output.
Vitamin K is given to the newborn by mouth (orally) in three doses, not as a single IM injection.
Exam impact
MLE questions on newborn drug administration frequently ask 'what dose and route' for Vitamin K. Answering 'oral' or giving the wrong dose loses marks and reflects incorrect EINC protocol knowledge.
The reality
In the Philippine setting and under EINC/Unang Yakap protocols, the standard is a SINGLE IM INJECTION of Vitamin K1 (phytomenadione): 1 mg IM for term newborns (birth weight ≥1.5 kg) and 0.5 mg IM for preterm/LBW newborns (<1.5 kg). It is given into the anterolateral thigh (vastus lateralis muscle), ideally within the first hour. The IM route provides reliable absorption regardless of feeding status and requires only one dose — a critical advantage in a community setting where follow-up is uncertain. The oral multi-dose regimen is NOT the Philippine DOH standard.
Trap question
Question
A healthy term baby boy weighing 3.2 kg is born at a lying-in clinic. To prevent Vitamin K Deficiency Bleeding (VKDB), the midwife should administer:
The Philippine DOH and EINC protocol specifies a SINGLE IM dose of Vitamin K1 — not oral dosing. For a term baby (≥1.5 kg), the dose is 1 mg IM. The vastus lateralis (anterolateral thigh) is the correct injection site for newborns. The oral multi-dose regimen is used in some other countries but is NOT the Philippine standard.
Wrong answer
Vitamin K1 1 mg orally in three separate doses on Day 1, Week 1, and Week 4.
Correct answer
Vitamin K1 (phytomenadione) 1 mg in a single IM injection into the anterolateral thigh, given within the first hour of birth.
Correct vs incorrect approach
Correct approach
Under DOH/EINC: give Vitamin K1 (phytomenadione) 1 mg IM (0.5 mg for preterm/LBW) as a SINGLE injection into the anterolateral thigh within the first hour of birth. Document on the newborn record.
Incorrect approach
Student confuses international oral protocol → gives Vitamin K orally in 3 doses → DOH standard not followed → inconsistent absorption → risk of Vitamin K Deficiency Bleeding (VKDB/hemorrhagic disease of newborn) if follow-up fails.
Why students believe it
Some countries use an oral Vitamin K protocol, and this information appears in international nursing and midwifery references that Filipino students access online. Students confuse the international oral regimen with the Philippine DOH/EINC standard, or they think oral is 'gentler' for babies. Some also confuse Vitamin K with oral vitamin supplements given to children.
After applying eye ointment (erythromycin) for ophthalmia neonatorum prophylaxis, the midwife should irrigate (rinse) the newborn's eyes with normal saline to prevent irritation.
Exam impact
MLE questions about eye prophylaxis frequently include 'irrigate afterward' as a distractor. Choosing irrigation as correct technique loses marks and demonstrates a misunderstanding of the procedure's pharmacological purpose.
The reality
After applying erythromycin 0.5% ophthalmic ointment (a thin ribbon in each lower conjunctival sac), the midwife must NOT irrigate the eyes. Irrigating washes away the prophylactic antibiotic before it can work, eliminating the entire protective effect against gonococcal and chlamydial ophthalmia neonatorum. The DOH/EINC instruction is explicit: apply the ointment, do not irrigate, do not touch or squeeze the eyes. Also, the eye ointment is applied AFTER the initial skin-to-skin bonding and drying (not immediately at birth) to allow eye-to-eye contact between mother and baby.
Trap question
Question
After applying erythromycin 0.5% ophthalmic ointment to a newborn's eyes for ophthalmia neonatorum prophylaxis, the midwife notices some ointment visible at the eye margins. What should the midwife do NEXT?
Irrigating after erythromycin ointment application washes away the antibiotic and negates the prophylaxis entirely. The DOH/EINC protocol explicitly states: do NOT irrigate the eyes after applying prophylaxis. Any excess ointment at the lid margin is acceptable and will clear naturally. Irrigation was historically done after silver nitrate (which caused more irritation), NOT after erythromycin.
Wrong answer
Gently irrigate the eyes with normal saline to remove excess ointment and prevent irritation.
Correct answer
Leave the eyes alone — do NOT irrigate. The ointment at the margins is expected and does not require removal.
Correct vs incorrect approach
Correct approach
After skin-to-skin contact and drying, apply a thin ribbon of erythromycin 0.5% ophthalmic ointment into the lower conjunctival sac of each eye → DO NOT irrigate → DO NOT wipe → document on newborn record.
Incorrect approach
Student applies erythromycin ointment → irrigates eyes with normal saline to 'remove excess' → ointment washed away → no prophylaxis → baby at risk for ophthalmia neonatorum → possible blindness.
Why students believe it
It seems logical: any chemical in the eye might cause irritation, and rinsing 'cleans' it. Students apply adult medication logic — 'if something gets in your eye, wash it out.' Some reviewees also confuse this with silver nitrate's historical requirement for irrigation (silver nitrate DID require irrigation, but erythromycin does NOT).
High-dose Vitamin A supplements can be given to pregnant women to improve fetal health and prevent neural tube defects.
Exam impact
Questions about antenatal supplementation frequently list Vitamin A as a distractor. Selecting high-dose Vitamin A as appropriate during pregnancy demonstrates a safety knowledge gap.
The reality
High-dose Vitamin A is ABSOLUTELY CONTRAINDICATED during pregnancy because it is TERATOGENIC — it causes serious birth defects including craniofacial malformations and heart defects in the fetus. The postpartum Vitamin A dose (200,000 IU as a single capsule) is given after delivery — NOT during pregnancy. During antenatal care, the midwife provides IRON + FOLIC ACID supplements, not high-dose Vitamin A. Folic acid (400 mcg/day) prevents neural tube defects; Vitamin A does not play this role and at high doses causes the opposite — malformations.
Trap question
Question
A midwife is conducting a first antenatal visit for a newly confirmed 8-week pregnant woman. Which of the following supplementation should the midwife provide?
High-dose Vitamin A (200,000 IU) is teratogenic and must NEVER be given during pregnancy. It is given postpartum — after the baby is born. The standard antenatal supplement is ferrous sulfate (60 mg elemental iron) combined with folic acid (400 mcg) once daily. This prevents iron-deficiency anemia and neural tube defects respectively.
Wrong answer
Vitamin A 200,000 IU capsule, ferrous sulfate, and folic acid.
Correct answer
Ferrous sulfate 60 mg + folic acid 400 mcg once daily. Vitamin A at high dose is contraindicated during pregnancy.
Correct vs incorrect approach
Correct approach
DURING PREGNANCY: give ferrous sulfate 60 mg + folic acid 400 mcg once daily throughout pregnancy and 3 months postpartum. AFTER DELIVERY: in line with DOH policy, Vitamin A 200,000 IU capsule may be given to the postpartum mother (within the first weeks after birth, while she is breastfeeding).
Incorrect approach
Student thinks 'Vitamin A = good for baby' → recommends high-dose Vitamin A capsule during pregnancy → teratogenic exposure in first trimester → severe fetal malformations.
Why students believe it
Vitamin A is widely associated with healthy fetal development and eye health. Students know that folic acid and iron are given during pregnancy, so they assume all micronutrients including high-dose Vitamin A are safe and beneficial. The Vitamin A supplementation program for postpartum mothers adds to the confusion about timing.
Combined Oral Contraceptives (COCs) are the best family planning choice for fully breastfeeding mothers because they are highly effective.
Exam impact
Family planning questions frequently test knowledge of postpartum contraception. Selecting COCs for a breastfeeding mother shows a critical gap in contraceptive eligibility knowledge.
The reality
COCs contain ESTROGEN, which suppresses milk production (lactation). They are NOT the first choice for fully breastfeeding (lactating) women, especially in the first 6 months postpartum. The preferred hormonal options for breastfeeding mothers are PROGESTIN-ONLY PILLS (POPs) or DMPA injectable (150 mg IM every 3 months) — these do NOT contain estrogen and do NOT suppress milk supply. COCs are also avoided in: smokers over 35, women with uncontrolled hypertension, and those with history of thromboembolism.
Trap question
Question
A 28-year-old G2P2 mother is exclusively breastfeeding her 6-week-old infant. She requests a highly effective hormonal contraceptive method. Which of the following is MOST appropriate?
COCs contain estrogen, which suppresses prolactin and reduces breast milk production — harmful for a breastfeeding infant. For lactating women, progestin-only methods (POPs or DMPA) are the preferred hormonal options because they are estrogen-free, highly effective, and do not affect milk supply. This is a fundamental family planning eligibility principle tested in the MLE.
Wrong answer
Combined oral contraceptive (COC) pills because they are highly effective.
Correct answer
Progestin-only pill (POP) or DMPA injectable (150 mg IM every 3 months).
Correct vs incorrect approach
Correct approach
For a BREASTFEEDING woman: recommend POPs (progestin-only pills) or DMPA (150 mg IM every 3 months) — both are estrogen-free and safe for milk supply. COCs can be considered after breastfeeding is well established (after 6 months) or when the mother has stopped breastfeeding.
Incorrect approach
Student sees 'highly effective method needed for postpartum woman who is breastfeeding' → recommends COC → estrogen in COC suppresses prolactin → reduced milk supply → infant underfed.
Why students believe it
COCs are the most recognized oral contraceptive method, and students associate 'highly effective' with 'best choice.' Without careful study of WHO/DOH eligibility criteria, reviewees assume effectiveness equals appropriateness in all women, including lactating mothers.
Oxytocin 10 IU IM for AMTSL can be given immediately at crowning (when the baby's head is visible), before the baby is fully born.
Exam impact
MLE items that describe the exact timing of AMTSL oxytocin administration test this very point. Choosing 'at crowning' or 'before delivery of baby is complete' is a patient-safety error that loses marks.
The reality
Oxytocin for AMTSL is given WITHIN ONE MINUTE AFTER THE BIRTH OF THE BABY — meaning after the COMPLETE delivery of the baby (both head AND body are out), AND after confirming there is NO SECOND TWIN. Giving oxytocin before the baby is fully born (or before excluding a second twin) would cause uterine hyperstimulation with the baby still inside, resulting in fetal distress, hypoxia, or uterine rupture. The sequence is: baby born completely → confirm no second twin → give oxytocin 10 IU IM within 1 minute → then proceed with controlled cord traction after placenta separates.
Trap question
Question
During a normal delivery at the lying-in clinic, the baby's head has just been born (head delivered, body not yet). There is no known second twin. When should the midwife administer oxytocin 10 IU IM for AMTSL?
Oxytocin must be given AFTER COMPLETE DELIVERY OF THE BABY. Administering it while the baby's body is still in the birth canal causes dangerous uterine contractions that can trap the baby, cause fetal hypoxia, or rupture the uterus. 'Within one minute of birth' means within one minute AFTER the baby is completely out and no second twin is present.
Wrong answer
Immediately now, since the head has been born and delivery is nearly complete.
Correct answer
After the COMPLETE birth of the baby (head and body fully delivered) and after confirming no second twin — within one minute of complete birth.
Correct vs incorrect approach
Correct approach
WAIT until baby is COMPLETELY delivered → confirm NO second twin → THEN give oxytocin 10 IU IM within 1 minute → proceed with gentle controlled cord traction only when placenta shows signs of separation.
Incorrect approach
Student sees 'give oxytocin as early as possible' → gives it at crowning before baby is fully out → uterus contracts forcefully around baby → hypoxia/fetal distress → emergency.
Why students believe it
The phrase 'within one minute of birth' creates confusion about WHEN the clock starts. Some students interpret 'as early as possible' to mean 'give it as soon as you know the baby is coming out.' Others mix up the instruction for AMTSL timing.
A midwife can prescribe and dispense antibiotics to treat postpartum infection or wound infection at the BHS because treating infection is part of maternal care.
Exam impact
Questions showing a postpartum patient with fever/infection frequently trap examinees who choose 'administer antibiotics' instead of 'refer.' This reflects a fundamental misunderstanding of the midwife's scope of practice.
The reality
Treating infections with antibiotics is BEYOND the midwife's scope under RA 7392. The midwife's role regarding infection is: DETECT signs and symptoms (fever >38°C, foul-smelling lochia, wound dehiscence, mastitis) → REFER immediately to a physician. The midwife is NOT a prescriber of antibiotics for infection treatment. The only narrow exception is a PRE-REFERRAL FIRST-DOSE antibiotic in a specific stabilization protocol (e.g., signs of severe sepsis before transport), which is a stabilizing emergency measure under a specific DOH/facility protocol — NOT routine prescribing. If a drug TREATS A DISEASE rather than SUPPORTS NORMAL BIRTH or PREVENTS A DEFINED DEFICIENCY, the answer is REFER.
Trap question
Question
On a home visit 5 days postpartum, a midwife notes that the patient has a temperature of 38.6°C, uterine tenderness, and foul-smelling lochia. What is the MOST appropriate initial action?
Signs of puerperal infection (fever >38°C, uterine tenderness, foul-smelling lochia) are a COMPLICATION beyond the midwife's scope of independent management. The midwife DETECTS and REFERS — she does NOT prescribe antibiotic courses. Independent antibiotic prescription and treatment of infections is a physician's responsibility. The midwife's action here is prompt referral.
Wrong answer
Administer the first dose of amoxicillin 500 mg and instruct the patient to continue the full antibiotic course.
Correct answer
Refer the patient immediately to a physician or higher-level health facility (RHU/hospital), documenting the findings.
Correct vs incorrect approach
Correct approach
Midwife sees fever and foul-smelling lochia → recognizes these as signs of puerperal infection (a complication) → REFERS immediately to physician/RHU/hospital → documents findings and provides comfort measures during transport.
Incorrect approach
Midwife sees postpartum patient with fever 38.5°C and foul-smelling lochia → diagnoses puerperal infection → independently prescribes amoxicillin → delays proper medical treatment → patient's condition worsens.
Why students believe it
Midwives provide postpartum care and routinely see infections (perineal wound infections, mastitis, fever). It seems logical that a primary maternal care provider should be able to give antibiotics to treat the infections they diagnose. Some reviewees also confuse 'dispensing in a DOH facility' with 'prescribing authority.'
Tetanus Toxoid Dose 1 (TT1/Td1) provides protection for the pregnancy — so if a pregnant woman received TT1, her baby is protected from neonatal tetanus.
Exam impact
MLE questions about tetanus protection frequently ask 'how many doses are needed to protect a pregnancy' or 'which dose first gives protection.' Answering TT1 gives protection is a common wrong answer.
The reality
TT1/Td1 gives NO protection. It is a priming dose only. The FIRST DOSE that provides protection is Td2, given at least 4 weeks after Td1, which gives approximately 3 years of protection and covers that pregnancy. A woman who has only received Td1 has NO protection against tetanus. This is a critical distinction in the MLE. The full schedule to achieve lifetime protection requires ALL FIVE doses (TT1–TT5). Neonatal tetanus protection requires the mother to have received at least Td2 (or be up to date with prior doses).
Trap question
Question
A pregnant woman comes to the BHS for her first antenatal check-up. Review of records shows she received Td1 one month ago during a previous visit. She is now 20 weeks AOG. What is the immunization status of her unborn baby regarding neonatal tetanus?
Td1 provides ZERO protection — it merely initiates the immune response. Protection begins only with Td2 (given ≥4 weeks after Td1), which provides approximately 3 years of protection and covers the current pregnancy. This is a commonly tested and commonly missed MLE item. Always ensure the mother receives at least Td2 during the current pregnancy.
Wrong answer
The baby is now protected because the mother has already received Td1.
Correct answer
The baby is NOT yet protected. Td1 is a priming dose with no protective effect. The midwife should administer Td2 now (at least 4 weeks after Td1) to confer protection for this pregnancy.
Correct vs incorrect approach
Correct approach
TT1/Td1 = NO protection (priming only). TT2/Td2 = FIRST dose with protection (~3 years, covers current pregnancy). TT3 = ~5 years. TT4 = ~10 years. TT5 = lifetime protection for all childbearing years. Always record immunization history and ensure woman receives at least Td2 during the current pregnancy.
Incorrect approach
Student sees 'woman received TT1' → assumes 'she is now protected and her baby is safe' → fails to prioritize giving TT2 at the next antenatal visit → woman delivers without protection → neonatal tetanus risk.
Why students believe it
Students remember that vaccines are given during pregnancy to protect the newborn, and they assume that receiving any dose means protection is conferred. The concept of 'immunity-building' is sometimes oversimplified to mean 'one dose = some protection = baby is safe.'
For a woman with PPH, the midwife's FIRST action should be to give more oxytocin — everything else (referral, uterine massage, bladder emptying) comes after establishing drug therapy.
Exam impact
PPH management questions on the MLE test whether examinees understand the integrated emergency response. Selecting drug administration BEFORE referral as the first priority reflects misplaced priorities in emergency maternal care.
The reality
In PPH at the BHS/community level, the midwife's PRIORITY ACTIONS follow this order: (1) CALL FOR HELP / INITIATE REFERRAL — because PPH is an obstetric emergency beyond definitive midwife management, (2) BIMANUAL UTERINE MASSAGE — immediate mechanical stimulation to contract the uterus, (3) GIVE OXYTOCIN (repeat dose or IV infusion as available), (4) EMPTY THE BLADDER — a full bladder prevents uterine contraction, (5) CHECK FOR TEARS — a source of continued bleeding. Drug administration is critical but simultaneous with referral — NOT before referral. The midwife stabilizes while transporting. Delaying referral to 'try the drug first' is dangerous.
Trap question
Question
A G1P1 patient delivers a live baby at the BHS. Two minutes after the placenta is delivered, the midwife notes heavy vaginal bleeding with an estimated blood loss of 700 mL. The uterus is soft and boggy. What is the midwife's FIRST priority action?
PPH (blood loss ≥500 mL after vaginal birth) is an obstetric emergency. The midwife's first priority is to CALL FOR HELP and INITIATE REFERRAL because definitive management (blood transfusion, surgical intervention) is beyond BHS capability. Uterine massage, oxytocin, bladder emptying, and checking for tears are performed SIMULTANEOUSLY while arranging transfer. Waiting to give a drug before referring is a life-threatening delay.
Wrong answer
Administer a repeat dose of oxytocin 10 IU IM and observe if bleeding decreases.
Correct answer
Call for help and initiate immediate referral to a higher-level facility, while simultaneously performing uterine massage and giving oxytocin.
Correct vs incorrect approach
Correct approach
PPH detected → (1) Shout for help / activate referral immediately, (2) Bimanual uterine massage, (3) Give oxytocin, (4) Empty bladder, (5) Check for tears → TRANSPORT to higher facility. Drug and massage are given WHILE arranging referral — never instead of it.
Incorrect approach
Student sees PPH → gives repeat oxytocin dose → waits to see if bleeding stops → delays referral → patient exsanguinates in the BHS without access to blood transfusion or surgical repair.
Why students believe it
Since oxytocin is the key PPH drug and it is well remembered, students default to 'give the drug first' as the standard clinical reflex. Drug administration feels like active clinical treatment, while referral and massage seem secondary or less urgent.
Quick self-check
A midwife may administer oxytocin during active labor to accelerate slow progress under her independent authority.
Answer
False
Oxytocin for induction or augmentation of labor is STRICTLY a physician's act. The midwife's oxytocin use is confined to the THIRD STAGE of labor (AMTSL) and PPH treatment AFTER the baby is born. Using oxytocin before delivery can cause uterine rupture and is outside the midwife's scope under RA 7392.
Oxytocin is the preferred first-line uterotonic for AMTSL because, unlike ergometrine, it does not raise blood pressure.
Answer
True
Oxytocin 10 IU IM is the drug of choice for AMTSL because it is effective AND does not cause vasoconstriction or hypertension. Ergometrine is second-line and contraindicated in hypertension, pre-eclampsia, and heart disease. Because BP status may be unknown in community settings, oxytocin is universally the safer first choice.
The MgSO4 loading dose for eclampsia is 4 g IV only. The IM component is an optional add-on.
Answer
False
The complete loading regimen requires BOTH routes: 4 g MgSO4 (20%) slow IV over 5–20 minutes PLUS 10 g MgSO4 (50%) IM — 5 g into each buttock, each mixed with 1 mL of 2% lignocaine. Both components are given simultaneously. The IV provides rapid therapeutic levels; the IM sustains levels during referral transport.
After applying erythromycin 0.5% ophthalmic ointment for newborn eye prophylaxis, the eyes should be gently rinsed with normal saline to remove excess medication.
Answer
False
Irrigating the eyes after erythromycin ointment application washes away the antibiotic and negates the entire prophylactic effect against ophthalmia neonatorum. The DOH/EINC protocol explicitly states: do NOT irrigate after application. Any visible ointment at the lid margins is expected and will clear on its own.
A breastfeeding mother requesting contraception should be offered progestin-only pills (POPs) or DMPA injectable rather than combined oral contraceptives (COCs) as the preferred hormonal option.
Answer
True
COCs contain estrogen, which suppresses prolactin and reduces breast milk production. For fully breastfeeding mothers, progestin-only methods (POPs or DMPA 150 mg IM every 3 months) are preferred because they are estrogen-free and do not affect milk supply. COCs are appropriate only after breastfeeding has been discontinued or well established beyond 6 months.
Receiving Tetanus/Td Dose 1 (TT1) provides the pregnant woman protection against maternal and neonatal tetanus.
Answer
False
TT1/Td1 is a PRIMING dose that provides NO protection. Protection begins only with TT2/Td2 (given at least 4 weeks after TT1), which confers approximately 3 years of protection and covers the current pregnancy. A woman who has received only TT1 has no protective immunity.
High-dose Vitamin A (200,000 IU) is safe to give during pregnancy as part of the routine antenatal micronutrient supplementation program.
Answer
False
High-dose Vitamin A is TERATOGENIC and ABSOLUTELY CONTRAINDICATED during pregnancy. It causes severe fetal malformations including craniofacial and cardiac defects. The 200,000 IU dose is given POSTPARTUM (after delivery, while the mother is breastfeeding) — never during pregnancy. The antenatal supplement is ferrous sulfate 60 mg + folic acid 400 mcg.
The patellar reflex must be present, the respiratory rate must be at least 12–16 breaths per minute, AND urine output must be at least 30 mL per hour before each MgSO4 dose — all three criteria must be met.
Answer
True
All three safety signs are mandatory before each MgSO4 dose: (1) patellar reflex present, (2) respiratory rate ≥12–16/min, and (3) urine output ≥30 mL/hr (or ≥100 mL/4 hr). Respiratory depression is the most lethal sign of toxicity. If ANY one criterion is not met, STOP MgSO4 and give calcium gluconate 1 g (10 mL of 10%) slow IV as the antidote.
Diagrams
Oxytocin: When a Midwife CAN vs. CANNOT Give It
This flowchart visually separates the ONE situation where a midwife can use oxytocin (after birth, for AMTSL/PPH) from the PROHIBITED use (induction/augmentation during labor). It reinforces the critical timing rule and the requirement to confirm no second twin before administration.
MgSO4 Loading Dose and Safety Monitoring — Complete Protocol
This flowchart shows the complete MgSO4 loading regimen (4g IV + 10g IM) and the three safety signs that must ALL be checked before giving the drug. It visually demonstrates that maintenance dosing is a physician/facility responsibility, and what to do if toxicity is suspected (calcium gluconate antidote).
The Midwife's Limited Formulary — What IS and IS NOT Included
This mind map provides a comprehensive visual overview of the midwife's complete limited formulary, clearly separating what IS permitted (with key details) from what is NOT within the midwife's scope. It serves as a visual summary of all drug-related misconceptions in this chapter.
Contraceptive Choice for Breastfeeding vs Non-Breastfeeding Postpartum Women
This decision flowchart guides students through contraceptive choice for postpartum women, visually showing why COCs are avoided in breastfeeding mothers (estrogen suppresses milk) and which methods are preferred. It reinforces the key family planning eligibility principle tested in the MLE.
In summary
Mastering the limited formulary is about understanding BOUNDARIES as much as knowing drug names and doses. These are the non-negotiable takeaways to prevent exam failure and unsafe practice: (1) Oxytocin has ONE timing window — AFTER the baby is born, for AMTSL or PPH. Never before. Never for labor augmentation. (2) Oxytocin beats ergometrine as first-line because it does not raise BP — remember this when BP is unknown. (3) MgSO4 loading is 4g IV + 10g IM simultaneously — never IV only. Monitor ALL THREE safety signs: RR ≥12, urine ≥30mL/hr, patellar reflex present. Antidote is calcium gluconate 1g IV. (4) Vitamin K1 for newborns is a SINGLE IM injection — 1mg term, 0.5mg preterm — in the anterolateral thigh. Not oral. (5) Eye ointment goes in, never gets rinsed out. (6) High-dose Vitamin A is teratogenic — give it POSTPARTUM, never in pregnancy. (7) TT1 protects nobody — TT2 is the first protective dose. (8) Breastfeeding mothers need estrogen-free contraception — POPs or DMPA, not COCs. (9) Infections, hypertension, augmentation, anesthesia — all belong to the physician. Detect and refer. The midwife's formulary supports NORMAL birth and DEFINED prevention. Anything that TREATS DISEASE goes to the doctor.